Shopping Cart 0
Cart Subtotal
USD 0

PsiOxus Therapeutics Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

PsiOxus Therapeutics Ltd (PsiOxus), formerly known as Myotec Therapeutics Ltd is a drug company that develops novel therapeutics for cancer and other clinically unmet diseases. The company provides pipeline product portfolio such as an oncolytic vaccine and a dual action anabolic catabolic transforming agent. It also has an antibody armed oncolytic platform under development. PsiOxus's products find application in the treatment of various cancer diseases such as cachexia, sarcopenia, metastatic cancer and solid tumours, among others. The company holds expertise in enhancing the therapeutic potency, safety and delivery kinetics through genetic modification to produce cancer vaccines. PsiOxus is headquartered in Abingdon, the UK.

PsiOxus Therapeutics Ltd-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

PsiOxus Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

PsiOxus Therapeutics Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

PsiOxus Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

PsiOxus Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

PsiOxus Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

PsiOxus Therapeutics Ltd, Pharmaceuticals & Healthcare, Deal Details 10

Venture Financing 10

PsiOxus Therapeutics Raises USD39.2 Million in Series C Financing 10

PsiOxus Therapeutics Raises Additional USD 34 Million In Series B Financing 12

Partnerships 14

PsiOxus Therapeutics Enters into Collaboration Agreement with Parker Institute for Cancer Immunotherapy 14

Bristol-Myers Squibb Enters into Agreement with PsiOxus Therapeutics 15

Parker Institute for Cancer Immunotherapy Enters into Agreement with PsiOxus Therapeutics 16

Licensing Agreements 17

Bristol-Myers Squibb Enters into Licensing Agreement with PsiOxus Therapeutics 17

Avidea Technologies Enters into Licensing Agreement with PsiOxus Therapeutics 18

PsiOxus Therapeutics Ltd-Key Competitors 19

PsiOxus Therapeutics Ltd-Key Employees 20

PsiOxus Therapeutics Ltd-Locations And Subsidiaries 21

Head Office 21

Recent Developments 22

Corporate Communications 22

Jun 04, 2018: PsiOxus Therapeutics Names Melissa Epperly As Chief Financial Officer 22

Aug 17, 2017: PsiOxus Therapeutics Announce Two New Board Appointments: Strengthens US Presence 23

Appendix 24

Methodology 24

About GlobalData 24

Contact Us 24

Disclaimer 24


List Of Figure

List of Figures

PsiOxus Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

PsiOxus Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

PsiOxus Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

PsiOxus Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

PsiOxus Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

PsiOxus Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

PsiOxus Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

PsiOxus Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List Of Table

List of Tables

PsiOxus Therapeutics Ltd, Pharmaceuticals & Healthcare, Key Facts 2

PsiOxus Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

PsiOxus Therapeutics Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

PsiOxus Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

PsiOxus Therapeutics Ltd, Deals By Therapy Area, 2012 to YTD 2018 8

PsiOxus Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

PsiOxus Therapeutics Raises USD39.2 Million in Series C Financing 10

PsiOxus Therapeutics Raises Additional USD 34 Million In Series B Financing 12

PsiOxus Therapeutics Enters into Collaboration Agreement with Parker Institute for Cancer Immunotherapy 14

Bristol-Myers Squibb Enters into Agreement with PsiOxus Therapeutics 15

Parker Institute for Cancer Immunotherapy Enters into Agreement with PsiOxus Therapeutics 16

Bristol-Myers Squibb Enters into Licensing Agreement with PsiOxus Therapeutics 17

Avidea Technologies Enters into Licensing Agreement with PsiOxus Therapeutics 18

PsiOxus Therapeutics Ltd, Key Competitors 19

PsiOxus Therapeutics Ltd, Key Employees 20

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

PsiOxus Therapeutics Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.